| 发明名称 | Melanoma antigen peptide and uses thereof | ||
| 摘要 | The present invention relates to a melanoma antigen peptide comprising the amino acids sequence selected in the group consisting of SEQ ID NO: 1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4 or SEQ ID NO:5 or a function-conservative variant thereof. Moreover the invention also relates to a melanoma antigen peptide according to the invention for use in the prevention or the treatment of melanoma in patient. | ||
| 申请公布号 | US9573975(B2) | 申请公布日期 | 2017.02.21 |
| 申请号 | US201214402803 | 申请日期 | 2012.05.22 |
| 申请人 | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE);UNIVERSITE DE NANTES;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS);UNIVERSITE D'ANGERS | 发明人 | Labarriere Nathalie;Lang François;Bobinet Mathilde;Rogel Anne |
| 分类号 | A61K38/00;A61K38/10;A61K38/16;A61K38/04;C07K7/08;A61K39/00;C07K14/47 | 主分类号 | A61K38/00 |
| 代理机构 | Whitham, Curtis & Cook, P.C. | 代理人 | Whitham, Curtis & Cook, P.C. |
| 主权项 | 1. A melanoma antigen peptide having less than 40 amino acids comprising an amino acid sequence selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4 and SEQ ID NO:5; or a fusion peptide comprising said amino acid sequence and a melanoma antigen peptide comprising the amino acids motif: TX2NDECWPX9(SEQ ID NO: 23), wherein X2 is leucine, methionine, valine, isoleucine or glutamine and X9 is alanine, valine or leucine; or a composition comprising said melanoma antigen peptide or said fusion peptide. | ||
| 地址 | Paris FR | ||